Clinical outcomes in patients with native valve infective endocarditis and diabetes mellitus

• Published in: World journal of cardiology 2021-01, Vol.13 (1), p.11-20
• Main Authors: Abe, Temidayo, Eyituoyo, Harry Onoriode, De Allie, Gabrielle, Olanipekun, Titilope, Effoe, Valery Sammah, Olaosebikan, Kikelomo, Mather, Paul
• Format: Article
• Language: English
• Subjects: Retrospective Study
• ISSN: 1949-8462; 1949-8462
• DOI: 10.4330/WJC.V13.I1.11

There is a lack of data on the clinical outcomes in patients with native valve infective endocarditis (NVIE) and diabetes mellitus (DM). To investigate (1) trends in the prevalence of DM among patients with NVIE; and (2) the impact of DM on NVIE outcomes. We identified 76385 with NVIE from the 2004 to 2014 National Inpatient Sample, of which 22284 (28%) had DM. We assessed trends in DM from 2004 to 2014 using the Cochrane Armitage test. We compared baseline comorbidities, microorganisms, and in-patients procedures between those with without DM. Propensity match analysis and multivariate logistic regression were used to investigate study outcomes in in-hospital mortality, stroke, acute heart failure, cardiogenic shock, septic shock, and atrioventricular block. Crude rates of DM increased from in 22% in 2004 to 30% in 2014. There were significant differences in demographics, comorbidities and NVIE risk factors between the two groups. Staphylococcus aureus was the most common organism identified with higher rates in patients with DM (33.1% 35.6%; < 0.0001). After propensity matching, in-hospital mortality (11.1% 11.9%; < 0.0001), stroke (2.3% 3.0%; < 0.0001), acute heart failure (4.6% 6.5%; = 0.001), cardiogenic shock (1.5% 1.9%; < 0.0001), septic shock (7.2% 9.6%; < 0.0001), and atrioventricular block (1.5% 2.4%; < 0.0001), were significantly higher in patients with DM. Independent predictors of mortality in NVIE patients with DM include hemodialysis, congestive heart failure, atrial fibrillation, staphylococcus aureus, and older age. There is an increasing prevalence of DM in NVIE and it is associated with poorer outcomes. Further studies are crucial to identify the clinical, and sociodemographic contributors to this trend and develop strategies to mitigate its attendant risk.